Uncovering the burden of tuberculosis in Algeria: a retrospective analysis from 2019 to 2024
Antonie van Leeuwenhoek · 2025
DOI: 10.1007/s10482-025-02096-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antonie van Leeuwenhoek, 2025. Verfasst von Amina Zergui und 7 weiteren Autor:innen. Beteiligte Einrichtung: Applied Microbiology Laboratory, Department of Biology, Faculty of Nature and Life Sciences, University of Oran 1 Ahmed Benbella, Oran, Algeria. amin…. Hauptthemen laut MEDLINE: Tuberculosis. Die Arbeit nennt 43 Literaturangaben.
Abstract (Originalsprache)
Tuberculosis (TB) remains a global health challenge, particularly in low- and middle-income countries. This retrospective study aimed to analyze the epidemiological patterns, clinical characteristics, and treatment outcomes of TB in Algeria. A total of 729 medical records from patients treated at a public health facility in Oran between January 2019 and June 2024 were reviewed. The study revealed a mean patient age of 35.7 years (SD ± 16.4), with cases ranging from 1 to 88 years. Males accounted for 55% of TB cases, maintaining a consistent predominance across the study period. TB manifested primarily in two forms: pulmonary TB (PTB) in 45% of cases and extrapulmonary TB (EPTB) in 50%, with a small proportion (5%) presenting both types. EPTB was more prevalent among females (55%) and pediatric patients, whereas PTB was more frequent in individuals over 40 years. Comorbidities were documented in 19% of patients, with diabetes (7.5%), hypertension (6.2%), and HIV (1.8%) being the most common, predominantly affecting those over 50 years. Diagnosis relied on microscopy (52%), radiology (45%), and culture (3%). Most patients (83%) were newly diagnosed, while 17% had relapsed. Treatment involved Category I (83%) and Category II (17%) regimens. Overall, treatment outcomes were favorable, with a 91% cure rate, 8% drug resistance, and mortality below 1%. Between 2019 and 2023, cure rates improved from 89 to 94%, while resistance declined from 10 to 6%. These findings provide valuable insights into TB trends in Algeria, guiding public health interventions for better disease control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Applied Microbiology Laboratory, Department of Biology, Faculty of Nature and Life Sciences, University of Oran 1 Ahmed Benbella, Oran, Algeria. amina.zergui@yahoo.fr.
- Department of Public Health and Epidemiology, Pediatric Hospital of Canastel, Oran, Algeria.
- Dr. Ouahrani Fethi Mustapha Hospital for Severe Burns, Oran, Algeria.
- Laboratory of Biology, Water and Environment, University 8 May 1945 of Guelma, Guelma, Algeria.
- Laboratory of Toxicology, Environment, and Health, Department of Biology, Faculty of Natural Science and Life, University of Science and Technology Mohamed-Boudiaf, Oran, Algeria.
- Biophysics and Nuclear Medicine Service, University Hospital of Oran November 1 st, Oran, Algeria.
Zitieren
APA
Zergui, A., Bouziani, N., Fidjel, K., Leksir, C., Merzouk, Y., Chentouf, F. H., Djaballi, I., & Kihal, M. (2025). Uncovering the burden of tuberculosis in Algeria: a retrospective analysis from 2019 to 2024. Antonie van Leeuwenhoek. https://doi.org/10.1007/s10482-025-02096-7
Vancouver
Zergui A, Bouziani N, Fidjel K, Leksir C, Merzouk Y, Chentouf FH, et al. Uncovering the burden of tuberculosis in Algeria: a retrospective analysis from 2019 to 2024. Antonie van Leeuwenhoek. 2025. doi:10.1007/s10482-025-02096-7
BibTeX
@article{Zergui2025,
author = {Zergui, Amina and Bouziani, Nacim and Fidjel, Kawtar and Leksir, Choubaila and Merzouk, Yamina and Chentouf, Fatima Hanane and Djaballi, Imane and Kihal, Mebrouk},
title = {Uncovering the burden of tuberculosis in Algeria: a retrospective analysis from 2019 to 2024},
journal = {Antonie van Leeuwenhoek},
year = {2025},
doi = {10.1007/s10482-025-02096-7}
}
EUVIMED